HCA Healthcare (HCA), the largest non-governmental operator of acute care hospitals in the U.S., has been highlighted as a strong growth stock, earning a Zacks #1 (Strong Buy) Rank and 'A' ratings for both its VGM and Growth Style Scores. The company is projected to achieve 23.4% year-over-year earnings growth for the current fiscal year, with seven analysts recently raising fiscal 2025 earnings estimates, pushing the consensus to $27.10 per share. This robust outlook, combined with an average earnings surprise of +12.4%, suggests HCA warrants consideration for growth-oriented portfolios.
HCA Healthcare, the largest non-governmental operator of acute care hospitals in the U.S., currently holds a Zacks #1 (Strong Buy) Rank, complemented by 'A' ratings for both its VGM and Growth Style Scores. This strong fundamental positioning is supported by its extensive operational footprint, comprising 190 hospitals and approximately 2,400 ambulatory sites across 20 states and the UK. The company is projected to deliver robust year-over-year earnings growth of 23.4% for the current fiscal year. Analyst sentiment for fiscal 2025 is notably positive, with seven analysts revising their earnings estimates upwards in the last 60 days, elevating the Zacks Consensus Estimate by $0.93 to $27.10 per share. HCA's operational strength is further evidenced by its impressive average earnings surprise of +12.4%, indicating a consistent ability to exceed market expectations. This track record, combined with favorable growth projections and strong analyst revisions, reinforces its appeal as a growth stock. The confluence of a top-tier Zacks Rank, excellent Style Scores, and positive earnings outlook positions HCA Healthcare as a compelling consideration for investors seeking high-quality growth opportunities within the healthcare sector.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment
